Surface Oncology to Present at the 39th Annual Cowen Healthcare Conference

NEXT STORY
Translate Bio to Present at the 39th Annual Cowen and Company Healthcare Conference
PREV STORY
Ascendis Pharma Announces Once-weekly TransCon™ Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

argenx reports first quarter 2017 financial results and provides business update

2 May 2017 Breda, the Netherlands/Ghent, Belgium argenx (Euronext Brussels: ARGX), a clinical-stage biotechnology ...

author_avatar
NASDAQ Market News

AMAG Announces First Patient Enrolled in Phase 2b/3a Digoxin Immune Fab Study Conducted by Velo Bio

WALTHAM, Mass., June 01, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced ...

author_avatar
NASDAQ Market News

Dr. Yaron Pereg Appointed as New Chief Development Officer

TEL AVIV, Israel, Jan. 30, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), ...

author_avatar
NASDAQ Market News